Anticancer evaluation and molecular docking of new pyridopyrazolo-triazine and pyridopyrazolo-triazole derivatives.

Elmorsy, Mohamed R; Abdel-Latif, Ehab; Gaffer, Hatem E; Mahmoud, Samar E; Fadda, Ahmed A

Elmorsy, Mohamed R; Abdel-Latif, Ehab; Gaffer, Hatem E; Mahmoud, Samar E; Fadda, Ahmed A.

Affiliation

Elmorsy MR; Department of Chemistry, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt. m.r.elmorsy@gmail.com.
Abdel-Latif E; Department of Chemistry, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Gaffer HE; Dyeing, Printing and Auxiliaries Department, National Research Centre, Cairo, 12622, Egypt.
Mahmoud SE; Department of Chemistry, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.
Fadda AA; Department of Chemistry, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.

Sci Rep ; 13(1): 2782, 2023 02 16.

Article in En | MEDLINE | ID: mdl-36797448

Subject(s)

Antineoplastic Agents; Humans; Molecular Structure; Structure-Activity Relationship; Molecular Docking Simulation; Antineoplastic Agents/chemistry; Triazines/pharmacology; MCF-7 Cells; Triazoles/chemistry; Cell Proliferation; Drug Screening Assays, Antitumor; Cell Line, Tumor

Fulltext

XML

PubMed Links

Search on Google